Greater, broader SARS-CoV-2 neutralizing antibodies with third dose of vaccine
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
Sep 17, 2021
0
188